T-lymphocytes_NNS
from_IN
individuals_NNS
with_IN
filarial_JJ
inflammatory_JJ
disease_NN
have_VBP
increased_VBN
transendothelial_JJ
migration_NN
in_FW
vitro_FW
._.

The_DT
in_FW
vitro_FW
transendothelial_JJ
migration_NN
of_IN
circulating_VBG
filarial_JJ
antigen-specific_JJ
T-cells_NNS
was_VBD
examined_VBN
in_IN
Wuchereria_FW
banerofti_FW
infection_NN
._.

Circulating_VBG
T-cells_NNS
from_IN
individuals_NNS
with_IN
filaria-induced_JJ
lymphatic_JJ
pathology_NN
-LRB-_-LRB-
LP_NN
-RRB-_-RRB-
had_VBD
significantly_RB
greater_JJR
migration_NN
through_IN
unstimulated_JJ
HUVEC_NN
monolayers_NNS
than_IN
did_VBD
T-cells_NNS
from_IN
asymptomatic_JJ
infected_JJ
-LRB-_-LRB-
MF_NN
-RRB-_-RRB-
individuals_NNS
-LRB-_-LRB-
P_NN
=_JJ
0.04_CD
-RRB-_-RRB-
._.

In_IN
contrast_NN
to_TO
the_DT
MF_NN
individuals_NNS
where_WRB
no_DT
effect_NN
was_VBD
seen_VBN
,_,
transendothelial_JJ
migration_NN
of_IN
48-hr_JJ
filarial_JJ
antigen_NN
stimulated_JJ
T-cells_NNS
from_IN
LP_NN
individuals_NNS
was_VBD
significantly_RB
-LRB-_-LRB-
P_NN
=_JJ
0.01_CD
-RRB-_-RRB-
greater_JJR
than_IN
migration_NN
of_IN
48-hr_JJ
media-stimulated_JJ
T-cells_NNS
._.

In_IN
six_CD
of_IN
seven_CD
patients_NNS
examined_VBN
,_,
inhibition_NN
of_IN
the_DT
VLA-4_NN
\/_:
VCAM-1_NN
pathway_NN
resulted_VBD
in_IN
greater_JJR
than_IN
50_CD
%_NN
inhibition_NN
of_IN
transendothelial_JJ
migration_NN
of_IN
T-cells_NNS
._.

